Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BioNX Surgical is a regenerative medicine company that develops and distributes advanced biologic products for surgical and wound care applications. The company's portfolio is centered on human-derived placental tissues, including amniotic membranes and flowable amniotic matrices, which are processed to preserve natural growth factors and cytokines. These products are designed to modulate inflammation, reduce scar tissue formation, and accelerate the healing of soft tissue injuries. BioNX Surgical serves a variety of clinical specialties, including orthopedics, podiatry, and spine surgery, providing surgeons with tools to enhance patient recovery and outcomes. Headquartered in Atlanta, Georgia, the company focuses on delivering high-quality, safe, and effective regenerative solutions to the surgical community.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BioNX Surgical.